Status: open
Medicis Pharmaceutical Corp.; Impax Laboratories, Inc. (Solodyn)
Defendant: Medicis Pharmaceutical Corp.; Impax Laboratories, Inc.
Consumers who bought certain dosages of Solodyn and/or its generic version between July 23, 2009 and February 25, 2018 may be eligible for payment. The company reached a settlement over allegations of antitrust violations.